Status
Conditions
Treatments
About
The main purpose of study is to evaluate hypofractionated stereotactic radiotherapy (SBRT) using CyberKnife for Patients with low and intermediate risk of progression prostate cancer.
Full description
Evaluation of the usefulness expression of selected proteins (PTEN, SMAD4, Cyclin D1, SPP1) as prognostic and predictive factors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
600 participants in 1 patient group
Loading...
Central trial contact
Sylwia Krąkowska, MD; Piotr Milecki, PhD., MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal